Neurofibromatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1
Condition:   Neurofibromatosis 1 Intervention:   Other: Transcranial direct current stimulation Sponsor:   University of Manchester Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2021 Category: Research Source Type: clinical trials

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
Conditions:   Neurofibromatosis 1;   Plexiform Neurofibroma;   NF1 Intervention:   Drug: FCN-159 Sponsor:   Shanghai Fosun Pharmaceutical Development Co, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2021 Category: Research Source Type: clinical trials